Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 41 to 50 of 60

TitleReference numberPublishedLast updated
Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxaneTA458
L-Dex U400 for lymphoedema after breast cancer treatmentMIB111
Everolimus with exemestane for treating advanced breast cancer after endocrine therapyTA421
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimensTA423
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancerTA424
Axxent electronic brachytherapy system for early stage breast cancerMIB76
Breast cancerQS12
Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancerHTG315
Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumabESNM13
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancerTA263

Results per page

  1. 10
  2. 25
  3. 50
  4. All